UnitedHealth Faces Large Outpatient Divestiture To Resolve Antitrust Suit Related To Amedisys Deal

UnitedHealth Group Inc. (NYSE:UNH) would divest more than 160 healthcare facilities as part of a proposed settlement with the U.S. Department of Justice (DOJ) to resolve antitrust concerns surrounding its $3.3 billion acquisition of Amedisys Inc. (NASDAQ:AMED).

The agreement, announced Thursday, also includes a $1.1 million civil penalty against Amedisys for providing inaccurate information during the regulatory review process.

What Happened?

The DOJ’s Antitrust Division, alongside several state co-plaintiffs, argued that the deal would harm competition in the home health and hospice care sectors. In November 2024, the DOJ sued to block the deal.

Also Read: UnitedHealth Misses Q2 Mark But Vows A Healthier 2026

UnitedHealth’s Optum unit’s ...